Weidinger S, Bieber T, Cork MJ, Reich A, et al. Safety and efficacy of amlitelimab, a fully human, non-depleting, non-cytotoxic anti-OX40Ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomised placebo-controlled trial. Br J Dermatol 2023 Jul 18:ljad240. doi: 10.1093.
PMID: 37463508